David Fairley and Alan Williams accept invitation to join Offspring Biosciences Board of Directors
David Fairley and Alan Williams accept invitation to join Offspring Biosciences Board of Directors Posted Jan 21, 2021 Södertälje, January 21, 2021 -- Offspring Biosciences AB, a leading global provider of advanced molecular pathology services, announced that its Board of Directors has elected David Fairley and Alan Williams as Non-Executive Directors effective today. David Fairley, currently Chief Executive Officer of Histopath Consulting Ltd, and previously Managing Director and owner of Histologix Ltd, which he took from startup through to sale, has been involved in a r...
Source: biopharmadive.com